Abstract
The efficacy of potassium-verapamil cardioplegia for myocardial protection was studied using the canine heart preservation and transplantation system. Coronary vascular washout of the grafts was performedvia the aortic root both in Group I (n=8) with 4°C high potassium cardioplegic solution and in Group II (n=8) with 4°C high potassium and 1 mg/L verapamil solution. The heart were immersed into the same solution as used for washout and stored at 4°C for 6 hours, without oxygenation and perfusion. The grafts were transplanted orthotopically under conditions of cardiopulmonary (CP) bypass. Adequate hemodynamics without the support of CP bypass was obtained in all the grafts of Group II during a 2-hour observation period. In contrast, only five out of eight grafts in Group I were able to support the recipient circulation. Contraction bands were more prominently and frequently observed in the histology in Group I. Thus, the combination of coronary vascular washout with cold potassiumverapamil cardioplegia and storage at 4°C with the same solution seems to be effective for myocardial protection of the canine heart in cases of orthotopic transplantation.
Similar content being viewed by others
References
Gay, W. A. Jr. and Ebert P. A.: Functional metabolic, and morphological effects of potassium-induced cardioplegia. Surgery 74: 284–290, 1973.
Pinsky, W. W., Lewis, R. M., McMillin-Wood, J. B., Hara, H., Hartley, C. J., Gillette, P. C. and Entman, M. L.: Myocardial protection from ischemic arrest: potassium and verapamil cardioplegia. Am. J. Physiol. 9: H326-H335, 1981.
Collins, G. M., Bravo-Schugarman, M. and Terasaki, P. I.: Kidney preservation for transplantation. Lancet 1: 1219–1220, 1969.
Sacks, S. A., Petritsch, P. H. and Kaufman, J. J.: Canine kidney preservation using a new perfusate. Lancet 1: 1024–1028, 1973.
Lower, R. R. and Shumway, N. E.: Studies on orthotopic homotransplantation of the canine heart. Surg. Forum 11: 18–19, 1960.
Morishita, Y.: Orthotopic allotransplantation of the preserved canine heart. Acta Med. Univ. Kagoshima. 16: 107–125, 1974.
Ebert, P. A.: Aspects of myocardial protection. Ann. Thorac. Surg. 26: 495–496, 1978.
Bleese, N., Döring, V., Kalmar, P., Pokar, H., Polonius, J., Steiner, D. and Rodewald, G.: Intraoperative myocardial protection by cardioplegia in hypothermia. J. Thorac. Cardiovasc. Surg. 75: 405–413, 1978.
Ellis, R. J., Mangano, D., Vandyke, D. and Ebert, P. A.: Protection of myocardial function not enhanced by high concentration of potassium during cardioplegic arrest. Am. Assoc. Thorac. Surg., 59th Annual Meeting, 1979, p. 58.
Reitz, B. A., Brady, W. R., Hickey, P. R. and Michaelis, L. L.: Protection of the heart for 24 hr with intracellular (High K+) solution and hypothermia. Surg. Forum 25: 149–151, 1974.
Jennings, R. B., Sonners, H. M., Herdon, P. B. and Kaltenbach, J. P.: Ischemic injury of myocardium. Ann. New York Acad. Sci. 156: 61–78, 1969.
Watts, J. A., Koch, C. D. and LaNone, K. F.: Effects of Ca2+ antagonism: Ca2+ and heart function after ischemia. Am. J. Physiol. 7: H909-H916, 1980.
Sperelakis, N. and Schneider, J. A.: A metabolic control mechanism for calcium ion influx that may protect the ventricular myocardial cell. Am. J. Cardiol. 37: 1079–1085, 1976.
Proctor, E. and Jones, G. R. N.: In vitro assessment of preserved dog hearts, with some reference to preserved dog kidneys. Pegg, D. E., ed. In Organ Preservation. A symposium held at the Clinical Research Center. Harrow, 1972.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morishita, Y., Saigenji, H., Umebayashi, Y. et al. Potassium-verapamil cardioplegia for myocardial protection: An experimental evaluation through preservation and transplantation. The Japanese Journal of Surgery 13, 524–529 (1983). https://doi.org/10.1007/BF02469497
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469497